Top 5 Stocks to Buy Now
→ The Treasury just bought its own debt (From Golden Portfolio) (Ad)tc pixel
NASDAQ:OSRH

OSR Q1 2025 Earnings Report

OSR logo
$0.35 -0.01 (-2.77%)
As of 11:24 AM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

OSR EPS Results

Actual EPS
-$1.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

OSR Revenue Results

Actual Revenue
$0.76 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OSR Announcement Details

Quarter
Q1 2025
Date
5/20/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

OSR Earnings Headlines

OSR Holdings Rebrands as OSR Health in Name Change
June 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/osr-holdings-rebrands-as-osr-health-in-name-change?utm_source=marketbeat.com&utm_medium=referral
OSR Holdings Secures VXM01 Rights in Asset Deal
June 2, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/osr-holdings-secures-vxm01-rights-in-asset-deal?utm_source=marketbeat.com&utm_medium=referral
Four winners over 400%. Here's #5
CFA and CMT analyst Garrett Goggin called G2 Goldfields before it rose 1,023%, Reunion Gold before 538%, Highlander Silver before 741%, and Orogen Royalty before 416%. He also publicly predicted Newmont's 126% gain in 2025. Now Goggin says the 1974 petrodollar agreement between Washington and Riyadh has quietly expired, central banks are buying gold at the fastest pace since 1950, and a major monetary shift is underway. He has identified four specific positions - plus two bonus opportunities for readers.tc pixel
June 24 at 1:00 AM  |  Golden Portfolio (Ad)
OSR Holdings, Inc.: OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction
May 28, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68607121-osr-holdings-inc-osr-holdings-acquires-full-vxm01-intellectual-property-portfolio-in-dollar-30-million-transaction-200.htm
OSR Holdings, Inc. Common Stock (OSRH) SEC Filings
May 2, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/osrh/sec-filings
OSRH stock rockets 60% on $815M immunotherapy deal — retail bulls eye $1 mark for the stock
April 30, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/osrh-stock-rockets-60-on-815m-immunotherapy-deal-retail-bulls-eye-1-mark-for-the-stock/ar-AA2272q4
See More OSR Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OSR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OSR and other key companies, straight to your email.

About OSR

OSR (NASDAQ:OSRH) Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

View OSR Profile
Earnings Tools